Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01882621 | Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients | unknown | Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02780778 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 23, 2016 |
| clinicaltrials |
| NCT02772107 | Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 132 | Chinese PLA General HospitalOTHER | 1 | May 17, 2016 | clinicaltrials |
| NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013(CBPC) | unknown | Phase 3 | 164 | University Hospital, AngersOTHER_GOV | 1 | Apr 25, 2016 | clinicaltrials |
| NCT00257608 | A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) | completed | Phase 3 | 1,145 | Genentech, Inc.INDUSTRY | 17 | Apr 18, 2016 | clinicaltrials |
| NCT01082549 | Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)(ECLIPSE) | completed | Phase 3 | 780 | SanofiINDUSTRY | 14 | Mar 17, 2016 | clinicaltrials |
| NCT00216125 | Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer | completed | Phase 3 | 243 | Nasser Hanna, M.D.OTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT00198354 | Stage I/II NSCLC Perioperative Chemotherapy | completed | Phase 3 | 530 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00930891 | Bevacizumab in Extensive Small Cell Lung Cancer(CPC) | completed | Phase 2 / Phase 3 | 143 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00976456 | Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer(65plus) | completed | Phase 3 | 271 | PD Dr. med. Wolfgang SchuetteOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01058902 | The Effect Of Aspirin On Survival in Lung Cancer | withdrawn | Phase 3 | 0 | Liverpool Heart and Chest Hospital NHS Foundation TrustOTHER | 1 | Mar 7, 2016 | clinicaltrials |
| NCT01355484 | Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 321 | GTxINDUSTRY | 1 | Mar 3, 2016 | clinicaltrials |
| NCT00123760 | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | completed | Phase 2 / Phase 3 | 10,838 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01769066 | Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC | completed | Phase 2 / Phase 3 | 117 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00961415 | AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 3 | 376 | Hoffmann-La RocheINDUSTRY | 12 | Feb 22, 2016 | clinicaltrials |
| NCT01310387 | Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)(APM) | completed | Phase 3 | 79 | Chonnam National University HospitalOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT01326767 | Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring(CEPAC-TDM) | completed | Phase 3 | 366 | Central European Society for Anticancer Drug ResearchOTHER | 2 | Jan 27, 2016 | clinicaltrials |
| NCT00812266 | Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) | terminated | Phase 3 | 281 | Danish Oncological Lung Cancer GroupOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT00349219 | TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer(TORCH) | completed | Phase 3 | 760 | National Cancer Institute, NaplesOTHER | 2 | Jan 15, 2016 | clinicaltrials |
| NCT00345059 | The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer(DISTAL-2) | terminated | Phase 3 | 84 | National Cancer Institute, NaplesOTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT02643407 | Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer | unknown | Phase 3 | 488 | Guangdong Association of Clinical TrialsOTHER | 1 | Dec 31, 2015 | clinicaltrials |
| NCT00112294 | Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 755 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00762034 | A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 3 | 939 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 21, 2015 | clinicaltrials |
| NCT00883779 | A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 3 | 451 | Hoffmann-La RocheINDUSTRY | 7 | Dec 14, 2015 | clinicaltrials |
| NCT02629848 | Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer | terminated | Phase 3 | 401 | TakedaINDUSTRY | 0 | Dec 14, 2015 | clinicaltrials |
| NCT00409188 | Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)(START) | completed | Phase 3 | 1,513 | EMD SeronoINDUSTRY | 33 | Nov 20, 2015 | clinicaltrials |
| NCT00002550 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 3 | 429 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT01348126 | Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer(GALAXY) | terminated | Phase 2 / Phase 3 | 385 | Synta Pharmaceuticals Corp.INDUSTRY | 13 | Nov 5, 2015 | clinicaltrials |
| NCT00738881 | Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer(MARVEL) | terminated | Phase 3 | 23 | National Cancer Institute (NCI)NIH | 2 | Oct 29, 2015 | clinicaltrials |
| NCT02395939 | Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL(CT-CROP) | unknown | Phase 3 | 158 | Middlemore Hospital, New ZealandOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT00373425 | A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors(RADIANT) | completed | Phase 3 | 1,252 | OSI PharmaceuticalsINDUSTRY | 19 | Sep 17, 2015 | clinicaltrials |
| NCT00460317 | MONET1-MOtesanib NSCLC Efficacy and Tolerability Study | terminated | Phase 3 | 1,450 | AmgenINDUSTRY | 0 | Sep 7, 2015 | clinicaltrials |
| NCT00210080 | A Study to Diagnose Lung Cancer by Sputum Cytology (01-312) | completed | Phase 3 | 700 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 4, 2015 | clinicaltrials |
| NCT00050336 | Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) | terminated | Phase 3 | 702 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 27, 2015 | clinicaltrials |
| NCT01183858 | A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) | completed | Phase 3 | 315 | Hoffmann-La RocheINDUSTRY | 9 | Aug 19, 2015 | clinicaltrials |
| NCT02518802 | Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 3 | 220 | Tang-Du HospitalOTHER | 1 | Aug 10, 2015 | clinicaltrials |
| NCT01444118 | A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients(NSCLC) | terminated | Phase 3 | — | Bioven EuropeINDUSTRY | 1 | Jul 22, 2015 | clinicaltrials |
| NCT01282151 | TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer(TRAIL) | terminated | Phase 3 | 148 | Chonnam National University HospitalOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT01017874 | A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer | completed | Phase 3 | 236 | Eli Lilly and CompanyINDUSTRY | 5 | Jul 8, 2015 | clinicaltrials |
| NCT02393664 | Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung Resection | unknown | Phase 2 / Phase 3 | 300 | National Taiwan University HospitalOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT02486354 | Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy | completed | Phase 3 | 128 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 1, 2015 | clinicaltrials |
| NCT02481661 | Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC | unknown | Phase 3 | 610 | Zhejiang Cancer HospitalOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT00581113 | Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases | terminated | Phase 3 | 8 | Virginia Commonwealth UniversityOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT01487499 | Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)(SCLC) | terminated | Phase 3 | 4 | University of FloridaOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00326378 | Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer | completed | Phase 3 | 434 | Samsung Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00676507 | Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy(STOP) | completed | Phase 3 | 532 | NovaRx CorporationINDUSTRY | 8 | May 8, 2015 | clinicaltrials |
| NCT00172042 | A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 437 | Novartis PharmaceuticalsINDUSTRY | 15 | May 4, 2015 | clinicaltrials |
| NCT01379976 | Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer | terminated | Phase 3 | 107 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT00420160 | Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women? | completed | Phase 2 / Phase 3 | 59 | The Miriam HospitalOTHER | 1 | Apr 14, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jun 1, 2016source: clinicaltrials